MedTrace Logo

Testing the Effect of the InsuPad Device in Daily Life Conditions

NCT01594801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2013-03-13

No results posted yet for this study

Summary

This is the test protocol for the InsuPad device. The aim of the study is to show economical benefit when using the InsuPad device, by testing the effect of the InsuPad device on reducing injected insulin dose while keeping the same overall glycaemic control.

Conditions

  • Diabetics Mellitus Type 1
  • Diabetes Mellitus Type 2

Interventions

DEVICE

InsuPad

Use of the InsuPad for at least 3 times a day.

Sponsors & Collaborators

  • Insuline Medical Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-02-28
Completion
2013-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01594801 on ClinicalTrials.gov